Featured Research

from universities, journals, and other organizations

Small subset of normal white blood cells gives rise to a rare leukemia, study shows

Date:
March 1, 2011
Source:
Ohio State University Medical Center
Summary:
New research has identified a small subset of normal white blood cells in the body that can give rise to large granular lymphocyte leukemia, a rare incurable form of leukemia. The disease occurs in white blood cells called NKT cells, immune cells that share features of T lymphocytes and features of natural killer (NK) cells.

New research has identified a small subset of normal white blood cells in the body that gives rise to a rare incurable form of leukemia.

Related Articles


The study, led by investigators at The Ohio State University Comprehensive Cancer Center -- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC -- James), shows that large granular lymphocyte leukemia can occur in a small subset of white blood cells called NKT cells. NKT cells share features of immune cells called T lymphocytes and features of immune cells called natural killer (NK) cells.

The discovery, published online in the Journal of Clinical Investigation, arose from studies investigating why a mouse strain engineered to overexpress interleukin-15 often develops large granular lymphocyte leukemia, a disease more common in Asia than the United States, and it points to new ways to prevent the malignancy.

The researchers show that, in mice and in humans, the novel subset of NKT cells responsible for large granular lymphocyte leukemia are marked on their surface by a protein called NKp46. Only small numbers of these cells are present in mice and in humans. The study further shows that overexpression of interleukin-15 can drive these cells but not others to become leukemic.

"These novel NKT cells represent a small white-blood-cell population in normal mice or healthy humans, but they have the potential to develop into large granular lymphocyte leukemia under certain circumstances, such as a high interleukin-15 environment," says first author Jianhua Yu, a research scientist with the OSUCCC -- James.

"Our work suggests that targeting interleukin-15 signaling and NKp46 might offer a new way to prevent this leukemia as we learn more about who is susceptible," notes principal investigator Dr. Michael A. Caligiuri, director of Ohio State's Comprehensive Cancer Center and CEO of the James Cancer Hospital and Solove Research Institute. "In fact, we show that using an antibody to block interleukin-15 prevents large granular lymphocyte leukemia development in this mouse model.


Story Source:

The above story is based on materials provided by Ohio State University Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jianhua Yu. NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human. JCI, 2011 DOI: 10.1172/JCI43242

Cite This Page:

Ohio State University Medical Center. "Small subset of normal white blood cells gives rise to a rare leukemia, study shows." ScienceDaily. ScienceDaily, 1 March 2011. <www.sciencedaily.com/releases/2011/03/110301122004.htm>.
Ohio State University Medical Center. (2011, March 1). Small subset of normal white blood cells gives rise to a rare leukemia, study shows. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2011/03/110301122004.htm
Ohio State University Medical Center. "Small subset of normal white blood cells gives rise to a rare leukemia, study shows." ScienceDaily. www.sciencedaily.com/releases/2011/03/110301122004.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

U.S. Ebola Response Measures Demonstrated

U.S. Ebola Response Measures Demonstrated

AP (Oct. 31, 2014) Officials in the Washington area showed off Ebola response measures being taken at Dulles International Airport and the National Institutes of Health. (Oct. 31) Video provided by AP
Powered by NewsLook.com
Fauci Says Ebola Risk in US "essentially Zero"

Fauci Says Ebola Risk in US "essentially Zero"

AP (Oct. 30, 2014) NIAID Director Anthony Fauci said the risk of Ebola becoming an epidemic in the U.S. is essentially zero Thursday at the Washington Ideas Forum. He also said an Ebola vaccine will be tested in West Africa in the next few months. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Nurse Defies Ebola Quarantine With Bike Ride

Nurse Defies Ebola Quarantine With Bike Ride

AP (Oct. 30, 2014) A nurse who vowed to defy Maine's voluntary quarantine for health care workers who treated Ebola patients followed through on her promise Thursday, leaving her home for an hour-long bike ride. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Pot-Infused Edibles Raise Concerns in Colorado

Pot-Infused Edibles Raise Concerns in Colorado

AFP (Oct. 30, 2014) Colorado may have legalized marijuana for recreational use, but the debate around the decision still continues, with a recent - failed - attempt to ban cannabis-infused edibles. Duration: 01:53 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins